Kaiser Permanente-Roseville Medical Center

Roseville, California 95661

5 studies enrolling now · 10 studies all time

What they study most

Acute Lymphoblastic Leukemia, Advanced Solid Tumors, Antibiotic Stewardship, Breast Cancer, Carcinoma, Non-Small-Cell Lung, Chronic Lymphocytic Leukemia, Hemophilia A, Lymphoblastic Leukemia, Lymphoma, Non-Hodgkin, Multiple Myeloma, NSCLC, Neonatal Sepsis, Late-Onset

Studies at this site

• A Study to Evaluate the Safety and Efficacy of BGB-16673 Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma — Recruiting now
• A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) — Recruiting now
• TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer — Recruiting now
• A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting — Recruiting now
• Vancomycin Reduction Practices (VRP) in the NICU — Recruiting now
• Enhanced Dermatological Care to Reduce Rash and Paronychia in Epidermal Growth Factor Receptor (EGRF)-Mutated Non-Small Cell Lung Cancer (NSCLC) Treated First-line With Amivantamab Plus Lazertinib — Running, not enrolling
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC — Running, not enrolling
• Study of a Gene Therapy Treatment for Hemophilia A — Withdrawn before enrolling
• An Open-Label Study of JZP-458 (RC-P) in Patients With Acute Lymphoblastic Leukemia (ALL)/Lymphoblastic Lymphoma (LBL) — Completed